InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Ekman Lars, Director. Officer active across 2 companies, notably Ultragenyx Pharmaceutical Inc.. Aggregated, 7 reports have been logged. Activity tracked since 24 June 2021. The latest transaction was disclosed on 3 January 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Ekman Lars
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
15,834 shares@ US$6.4115.7% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-23-000574:0
15,834 shares@ US$6.4116.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-044319:0
15,833 shares@ US$6.4116.9% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-039911:0
15,833 shares@ US$6.4117.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-22-018291:0
31,666 shares@ US$6.4134.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-22-035561:0
3,300 shares0Common StockSEC:0001209191-22-039567:0
2,145 shares0Common StockSEC:0001209191-21-043543:0
7 of 7 declarations
About Ekman Lars
Lars Ekman is a Board Member at Ultragenyx Pharmaceutical Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and guiding research and development initiatives. With expertise in the pharmaceutical sector, Lars is well-positioned to provide valuable insights to the management team. His commitment to innovation and improving healthcare is essential for Ultragenyx.
